GLP-1 Medications and Calorie Tracking in 2026: Protein, Apps, and US Trends
GLP-1 receptor agonists — semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) — have reshaped weight management in the United States. By 2026, surveys suggest roughly 1 in 8 American adults has used a GLP-1 medication, roughly double the rate from 18 months earlier. That shift is changing what people need from calorie tracking apps.
Headline takeaway: On GLP-1 medications, the challenge often flips from eating less to eating enough — especially protein — to protect muscle during rapid weight loss.
New research: protein gaps on GLP-1
In April 2026, researchers published real-world dietary data from 332 adults using a mobile tracking app between July 2025 and February 2026. GLP-1 users ate significantly fewer calories than non-users (averaging around 1,102 vs. 1,628 kcal/day in the study sample).
The critical finding: weight-adjusted protein intake was low among GLP-1 users — about 0.6 g/kg/day, with 88% falling below Italy's national recommendation of 0.9 g/kg/day. International expert consensus published in Obesity Pillars recommends prioritizing protein during GLP-1-assisted weight loss to preserve lean mass, alongside fiber, hydration, and micronutrients.
For most adults, practical targets often land around 80–120 grams of protein per day, adjusted for body size and activity — but the exact number should come from a clinician or dietitian, not an app default.
Apps adding GLP-1-specific features
Major US trackers launched dedicated GLP-1 modules in 2026:
- MyFitnessPal GLP-1 Support (April 2026, free) — medication logging, injection reminders, and side-effect tracking alongside nutrition on the Today screen.
- MyNetDiary GLP-1 Companion (May 2026, Premium) — injection reminders, protein-focused tracking, digestive symptom logging, and GLP-1 meal planning.
- Specialist apps like Shotsy and Pep center the injection cycle, side effects, and protein-floor alerts for GLP-1-native workflows.
The category trend is clear: protein has replaced "calories remaining" as the headline macro for many GLP-1 users, because appetite suppression makes under-eating — not overeating — the bigger logging risk.
What to track if you are on a GLP-1
- Protein first: Log protein at every meal, even when total calories are low.
- Hydration: Dehydration worsens common GI side effects; water intake belongs in your daily review.
- Symptom patterns: Note nausea, constipation, or energy dips alongside what you ate and when you dosed.
- Weekly trends, not daily panic: Low appetite days vary; look at 7-day protein averages.
Important disclaimer
This article summarizes public news and research trends. It is not medical advice. GLP-1 dosing, nutrition targets, and side-effect management should be coordinated with your prescribing clinician.
MacroChat helps you log meals quickly in plain language and monitor macro trends — useful for hitting protein floors on low-volume eating days — but it does not replace professional medical guidance.